NCT03883945View on ClinicalTrials.gov

A Safety and Efficacy Study to Evaluate Rosacea

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

July 31, 2021

Primary Completion Date

July 31, 2022

Study Completion Date

August 31, 2022

Conditions
Papulopustular Rosacea
Interventions
DRUG

AIV001

intradermal injection

DRUG

Vehicle

intradermal injection

Trial Locations (1)

92121

Cosmetic Laser Dermatology, San Diego

Sponsors
All Listed Sponsors
lead

AiViva BioPharma, Inc.

INDUSTRY

NCT03883945 - A Safety and Efficacy Study to Evaluate Rosacea | Biotech Hunter | Biotech Hunter